MétaCan
Menu
Back to cohort
Record W4390062520 · doi:10.1038/s41572-023-00484-9

Central neuropathic pain

2023· review· en· W4390062520 on OpenAlexafffund
Jan Rösner, Daniel Ciampi de Andrade, Karen D. Davis, Sylvia M. Gustin, John L. K. Kramer, Rebecca P. Seal, Nanna Brix Finnerup

Bibliographic record

VenueNature Reviews Disease Primers · 2023
Typereview
Languageen
FieldMedicine
TopicPain Mechanisms and Treatments
Canadian institutionsInternational Collaboration On Repair DiscoveriesToronto Western HospitalUniversity of TorontoUniversity of British ColumbiaUniversity Health Network
FundersCanadian Institutes of Health ResearchHORIZON EUROPE Framework ProgrammeH. Lundbeck A/SNovo Nordisk FondenNovartis PharmaUniversität ZürichLundbeckfondenBiogenDanmarks GrundforskningsfondNational Institute of Neurological Disorders and StrokeTeva Pharmaceutical IndustriesNovo NordiskAarhus UniversitetInternational Foundation for Research in ParaplegiaRebecca L. Cooper Medical Research FoundationNational Research FoundationEli Lilly and Company
KeywordsNeuropathic painMedicineNeuroscienceCentral nervous systemStroke (engine)NeuromodulationChronic painSpinal cord injurySpinal cordAnesthesiaPsychologyPhysical therapyInternal medicine

Abstract

fetched live from OpenAlex

Central neuropathic pain arises from a lesion or disease of the central somatosensory nervous system such as brain injury, spinal cord injury, stroke, multiple sclerosis or related neuroinflammatory conditions. The incidence of central neuropathic pain differs based on its underlying cause. Individuals with spinal cord injury are at the highest risk; however, central post-stroke pain is the most prevalent form of central neuropathic pain worldwide. The mechanisms that underlie central neuropathic pain are not fully understood, but the pathophysiology likely involves intricate interactions and maladaptive plasticity within spinal circuits and brain circuits associated with nociception and antinociception coupled with neuronal hyperexcitability. Modulation of neuronal activity, neuron–glia and neuro-immune interactions and targeting pain-related alterations in brain connectivity, represent potential therapeutic approaches. Current evidence-based pharmacological treatments include antidepressants and gabapentinoids as first-line options. Non-pharmacological pain management options include self-management strategies, exercise and neuromodulation. A comprehensive pain history and clinical examination form the foundation of central neuropathic pain classification, identification of potential risk factors and stratification of patients for clinical trials. Advanced neurophysiological and neuroimaging techniques hold promise to improve the understanding of mechanisms that underlie central neuropathic pain and as predictive biomarkers of treatment outcome. Central neuropathic pain (CNP), that is, pain caused by a lesion of disease of the central somatosensory nervous system, severely impacts quality of life. In this Primer, Finnerup and colleagues review the epidemiology, pathophysiology, clinical presentation and diagnosis of CNP as well as discuss common therapeutic strategies and unmet clinical needs in this field.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.917
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0000.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.066
GPT teacher head0.387
Teacher spread0.321 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations126
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueNature Reviews Disease PrimersSame topicPain Mechanisms and TreatmentsFrench-language works237,207